Pacific Biosciences Of California | PACB - Operating Expenses


Pacific Biosciences Of California reported $97.83M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Agilent USD 1.44B 27M Dec/2025
Bruker USD 900.9M 124.3M Dec/2025
Danaher USD 5.34B 45.74B Dec/2025
General Electric Aerospace USD 10.94B 7.87B Dec/2025
Illumina USD 903M 69M Dec/2025
Myriad Genetics USD 212.8M 16.2M Dec/2025
Pacific Biosciences Of California USD 97.83M 41.29M Dec/2025
Quidel USD 760.9M 1.28B Dec/2025
Revvity USD 626.22M 25.62M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Standard Biotools USD 45.72M 2.7M Dec/2025
Thermo Fisher Scientific USD 9.91B 867M Dec/2025
Waters USD 661.85M 1.67B Dec/2025